HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Silverman, N. A. Articles by Levitsky, S. Search for Related Content PubMed PubMed Citation Articles by Silverman, N. A. Articles by Levitsky, S.

The Annals of Thoracic Surgery, Vol 40, 20-24, Copyright © 1985 by The Society of Thoracic Surgeons

ARTICLES

Effect of carnitine on myocardial function and metabolism following global ischemia

NA Silverman, G Schmitt, M Vishwanath, H Feinberg and S Levitsky

Carnitine has therapeutic potential for the postischemic heart by facilitating the oxidation of acylated fatty acid metabolites, the intracellular accumulation of which has a deleterious effect on myocardial function and metabolism. To test this hypothesis, two groups of dogs were given preischemic treatment with carnitine, 50 mg per kilogram of body weight (Group 1) or 100 mg/kg (Group 2), and were compared with untreated controls (N = 12 for all groups). The canine hearts underwent 30 minutes of global 37 degrees C ischemic arrest with reperfusion. Left ventricular systolic and diastolic function was assessed by an intracavitary balloon while metabolic derangements were quantitated by serial myocardial biopsies assayed for adenosine triphosphate (ATP). Comparable 49 to 53% (p less than 0.01) declines in preischemic ATP levels occurred during the study period in the controls and both experimental groups. However, postischemic systolic left ventricular function was better preserved in Group 2: these hearts generated 61 +/- 3% of preischemic peak developed pressure compared with 37 +/- 4% in the controls and 42 +/- 3% in Group 1 (p less than 0.01 for each), and 60 +/- 2% of preischemic maximum rate of rise of left ventricular pressure as opposed to 45 +/- 4% in the controls and 49 +/- 6% in Group 1 (p less than 0.02 for each).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				R Lango, R.T Smolenski, M Narkiewicz, J Suchorzewska, and W Lysiak-Szydlowska Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass Cardiovasc Res, July 1, 2001; 51(1): 21 - 29. [Abstract] [Full Text] [PDF]

				T. Sakamoto, M. Aoki, Y. Imai, and S. Nemoto Carnitine affects fatty acid metabolism after cardioplegic arrest in neonatal rabbit hearts Ann. Thorac. Surg., February 1, 2001; 71(2): 648 - 653. [Abstract] [Full Text] [PDF]

				V. A. Keller, B. Toporoff, R. M. Raziano, J. D. Pigott, and N. L. Mills Carnitine supplementation improves myocardial function in hearts from ischemic diabetic and euglycemic rats Ann. Thorac. Surg., November 1, 1998; 66(5): 1600 - 1603. [Abstract] [Full Text] [PDF]